Nanotech imaging, molecular fingerprints and signatures hold promise ...( iltration in to the lymphatic system t...),Health

iltration in to the lymphatic system, the surgeon can minimize the incision," Kobayashi said. "This method offers hope of improving the quality of life after surgery by limiting the surgery and perhaps negating the need for further painful chemotherapy when metastasis is evident to be contained within the sentinel node and not in downstream lymphatic structures."

The key to maximizing performance of G6 as a contrast reagent resids in the structure of the lymphatic vessels and nodes, Kobayashi said. The molecule needs to be small enough to rapidly enter the lymph ducts in the lymph fluids, yet large enough to remain within the lymphatics and not leech out into capillary vessels. The Johns Hopkins and NCI team tested G6, a dense (240 kDa) molecule with a span of 9 nanometers. The agent was tested using clinically dedicated MRI instrumentation to evaluate clinical setting performance. The performance of G6 was observed in mouse models for breast cancer.

The researchers looked at the rate of flow of G6 through the lymphatics system from the tumor site to determine "ultimate" sentinel nodes and confirmed that those lymph nodes are at greatest risk for initial spread of metastasis of breast cancer cells. Their technology detected 1 millimeter tumors in 3 millimeter lymph nodes, a 100-fold increase in the precision of detecting tumors than possible with existing conventional lymph node imaging technology. The resolution of this imaging technology distinguished both lymph nodes and ducts, which no other currently used method can discern. Furthermore, the technology visualized lymph nodes that had been totally displaced with cancer cells. Previously existing technology is unable to detect nodes fully occupied with cancer cells.

"This method can tell both the location of true sentinel lymph nodes and the presence or absence of metastatic cancer in those nodes within an hour by a single MRI study," Kobayashi said. "We validated the performanc
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Association for Cancer Research
28-Mar-2004

Page: 1 2 3 4 5
Related medicine news :

1. Nanotech control device developed
2. 3D neutron-based medical imaging, 4D lung scans, and hitting a moving tumor
3. Ultrasound-guided liposomes boost imaging, target drug/gene therapy
4. Mayo Clinic researchers report success in new molecular breast imaging technique
5. New molecular classification of breast cancer predicts response to chemotherapy
6. New tool reveals molecular signature of cancer and HIV
7. Researchers monitor progression of Parkinsons disease by studying molecular changes in brain
8. Stanford scientists help bring study of smallpox virus into molecular age
9. Tiny molecular motors shed light on cell function, say Stanford researchers
10. Improved molecular beacons show promise for cancer detection, rapid viral diagnosis
11. New study provides molecular-level understanding of common anti-malarial drugs